Cullinan Therapeutics (CGEM) Operating Margin (2021)
Cullinan Therapeutics has reported Operating Margin over the past 1 years, most recently at 7.24% for Q1 2021.
- Quarterly results put Operating Margin at 7.24% for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was 358.73% (changed N/A YoY), and the annual figure for FY2021 was 358.73%, changed.
- Operating Margin for Q1 2021 was 7.24% at Cullinan Therapeutics.
- Over the last five years, Operating Margin for CGEM hit a ceiling of 7.24% in Q1 2021 and a floor of 7.24% in Q1 2021.